Pregabalin Practice Review – Accessible version of data
These tables show the data for the graphs in the Practice Review Revisiting pregabalin: Optimising safety in prescribing for neuropathic pain
How has the prescribing of pregabalin and amitriptyline nationally changed over time?
|
2016-17 |
2017-18 |
2018-19 |
2019-20 |
|
|
pregabalin |
495754 |
516747 |
513153 |
502472 |
|
amitriptyline |
367477 |
388177 |
423313 |
442671 |
How has the rate of prescribing of pregabalin and amitriptyline nationally changed over time?
|
pregabalin median |
pregabalin 25th percentile |
pregabalin 75th percentile |
amitriptyline median |
amitriptyline 25th percentile |
amitriptyline 75th percentile |
|
|
2016-17 |
10 |
4 |
19 |
8 |
3 |
15 |
|
2017-18 |
10 |
4 |
20 |
8 |
4 |
15 |
|
2018-19 |
11 |
5 |
20 |
9 |
4 |
17 |
|
2019-20 |
10 |
5 |
20 |
10 |
5 |
17 |
What percentage of patients prescribed pregabalin in 2019-20 had a total of 1-2 prescriptions or 3 or more prescriptions dispensed?
|
national |
major city |
inner regional |
outer regional |
remote |
very remote |
|
|
1-2 prescriptions |
34 |
36 |
28 |
27 |
26 |
25 |
|
3 or more prescriptions |
66 |
64 |
72 |
73 |
74 |
75 |
What percentage of patients prescribed pregabalin in 2019-20 have more than one pregabalin prescriber?
|
national |
major city |
inner regional |
outer regional |
remote |
very remote |
|
|
one prescriber |
67 |
68 |
60 |
57 |
47 |
40 |
|
more than one prescriber |
33 |
32 |
40 |
43 |
53 |
60 |
What percentage of patients prescribed pregabalin in 2019-20 (nationally) also had one or more prescriptions for opioids and/or benzodiazepines dispensed in 2019-20?
|
% |
|
|
Neither an opioid or a benzodiazepine |
35% |
|
Either an opioid OR a benzodiazepine |
47% |
|
Both an opioid AND a benzodiazepine |
19% |